DWI与Kaiser评分结构化评估BI-RADS标准相比的附加价值:系统综述与Meta分析
该系统综述与Meta分析纳入截至2024年5月的5项研究(1005个恶性、846个良性乳腺病灶),比较DWI联合结构化BI-RADS评估与单独结构化BI-RADS评估的诊断效能。联合DWI后敏感度94.4%、特异度74.9%,单独评估敏感度95.7%、特异度68.7%,敏感度(P=0.52)与特异度(P=0.20)均无显著改变,提示DWI的附加价值有限且无统计学意义。
要点
- 联合DWI后敏感度94.4%、特异度74.9%,单独评估为95.7%和68.7%,差异均无统计学意义。
- Meta分析纳入5项研究共1005个恶性与846个良性乳腺病灶。
- DWI联合Kaiser评分结构化BI-RADS评估的附加价值有限且无统计学意义。
核心结论
- 该系统综述与Meta分析显示,与使用Kaiser评分结构化评估BI-RADS标准相比,DWI的附加价值有限且无统计学意义。
研究设计与样本
- 系统综述与Meta分析,纳入截至2024年5月发表的英文文献,共5项研究、1005个恶性病灶和846个良性病灶;采用双变量随机效应模型计算敏感度和特异度,并行I²统计、Deek漏斗图不对称检验及Meta回归分析。
诊断标准与关键数值
- 结构化BI-RADS评估的汇总敏感度为95.7%(95%CI 92.6%-97.5%),汇总特异度为68.7%(95%CI 60.9%-75.6%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This systematic review and meta-analysis investigated the added value of DWI compared with the structured assessment of BI-RADS criteria using the Kaiser score.
MATERIALS AND METHODS: Articles published in English until May 2024 were included. Two independent reviewers extracted data on the characteristics of studies evaluating the added value of DWI to distinguish benign from malignant breast lesions compared with structured assessment of the BI-RADS criteria. Using bivariate random-effects models, the sensitivity and specificity were calculated. I2 statistics, Deek's funnel plot asymmetry test for publication bias, and meta-regression were applied for the data analysis.
RESULTS: Five studies comprising 1005 malignant and 846 benign lesions were eligible for data synthesis. The pooled sensitivity and specificity estimates of structured BI-RADS assessment were 95.7% (95% confidence interval [CI], 92.6%-97.5%) and 68.7% (95% CI, 60.9%-75.6%), respectively. Adding DWI to the structured BI-RADS assessment achieved a pooled sensitivity of 94.4% (95% CI, 90.5%-96.7%) and a pooled specificity of 74.9% (95% CI, 68.8%-80.2%). Adding DWI to the structured BI-RADS assessment significantly changed neither the sensitivity ( P = 0.52) nor the specificity ( P = 0.20).
CONCLUSIONS: This systematic review and meta-analysis revealed only a limited, statistically nonsignificant added value of DWI compared with the structured assessment of BI-RADS criteria using the Kaiser score.
引用
- Dietzel M, Vatteroni G, Baltzer PAT, et al. What Is the Added Value of DWI Compared With Structured Assessment of BI-RADS Criteria by the Kaiser Score? A Systematic Review and Meta-analysis. Invest Radiol. 2024. PMID: 39724588. doi:10.1097/RLI.0000000000001123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。